NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 216 filers reported holding NEKTAR THERAPEUTICS in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $119 | +3.5% | 200 | 0.0% | 0.00% | – |
| Q2 2023 | $115 | -18.4% | 200 | 0.0% | 0.00% | – |
| Q1 2023 | $141 | -68.8% | 200 | 0.0% | 0.00% | – |
| Q4 2022 | $452 | -54.8% | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -90.0% | 200 | -89.6% | 0.00% | – |
| Q1 2022 | $10,000 | -61.5% | 1,930 | 0.0% | 0.00% | – |
| Q4 2021 | $26,000 | -25.7% | 1,930 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $35,000 | -16.7% | 1,930 | -20.6% | 0.00% | 0.0% |
| Q2 2021 | $42,000 | +250.0% | 2,430 | +305.0% | 0.00% | – |
| Q4 2019 | $12,000 | +20.0% | 600 | 0.0% | 0.00% | – |
| Q3 2019 | $10,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Strong Tower Advisory Services | 404,972 | $6,913,000 | 4.02% |
| GREAT POINT PARTNERS LLC | 504,691 | $9,064,000 | 2.11% |
| Camber Capital Management LP | 3,750,000 | $67,350,000 | 2.07% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,901,000 | 1.50% |
| Rhenman & Partners Asset Management AB | 950,000 | $17,062,000 | 1.20% |
| MAVERICK CAPITAL LTD | 5,838,426 | $104,858,000 | 1.06% |
| Birchview Capital, LP | 72,000 | $1,293,000 | 0.88% |
| Bellevue Group AG | 4,594,656 | $82,519,000 | 0.84% |
| CM Management, LLC | 50,000 | $898,000 | 0.67% |
| Duquesne Family Office | 1,000,000 | $17,960,000 | 0.58% |